Aphakic bullous keratopathy treated with prosthokeratoplasty. An analysis of 34 consecutive cases

Insights

The Cardona keratoprosthesis effectively treated advanced aphakic bullous keratopathy in 82% of eyes. This artificial cornea implant showed significant visual improvement, despite a 9% extrusion rate.

Area of Science:

  • Ophthalmology
  • Biomaterials Science
  • Surgical Innovation

Background:

  • Aphakic bullous keratopathy presents a significant challenge in corneal disease management.
  • Advanced cases often require complex surgical interventions beyond standard penetrating keratoplasty.
  • The Cardona keratoprosthesis offers an alternative prosthetic option for severe corneal opacity.

Purpose of the Study:

  • To evaluate the efficacy and safety of the Cardona keratoprosthesis as a primary treatment for advanced aphakic bullous keratopathy.
  • To compare the outcomes and complications of the Cardona keratoprosthesis with those of traditional penetrating keratoplasty.

Main Methods:

  • A cohort of 34 eyes with advanced aphakic bullous keratopathy underwent primary implantation of the Cardona keratoprosthesis.
  • Patient outcomes were monitored over follow-up periods ranging from 6 to 72 months.
  • Complications such as extrusion and infection were recorded and analyzed.

Main Results:

  • A notable improvement in visual function was observed in 28 out of 34 eyes (82%).
  • Complications included three device extrusions (9%), with two cases linked to infection.
  • Two eyes (6%) experienced worsened conditions due to vitreous hemorrhage or potential infection.

Conclusions:

  • The Cardona keratoprosthesis demonstrates significant potential for improving vision in eyes with advanced aphakic bullous keratopathy.
  • While effective, potential complications like extrusion and infection necessitate careful patient selection and monitoring.
  • This prosthetic approach offers a viable alternative to penetrating keratoplasty for specific patient profiles.

Related Concept Videos